Standard BioTools
LAB
LAB
131 hedge funds and large institutions have $854M invested in Standard BioTools in 2019 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 60 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
32% more funds holding
Funds holding: 99 → 131 (+32)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8.31% less ownership
Funds ownership: 101.5% → 93.19% (-8.3%)
Holders
131
Holding in Top 10
3
Calls
$302K
Puts
$40K
Top Buyers
| 1 | +$24.2M | |
| 2 | +$19.2M | |
| 3 | +$13.9M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$13.6M |
| 5 |
Renaissance Technologies
New York
|
+$12.1M |
Top Sellers
| 1 | -$125M | |
| 2 | -$3.88M | |
| 3 | -$3.45M | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$3.44M |
| 5 |
Neuberger Berman Group
New York
|
-$3.33M |